Chiusura precedente | 5,54 |
Aperto | 5,47 |
Denaro | 5,34 x 900 |
Lettera | 5,35 x 800 |
Min-Max giorno | 5,32 - 5,60 |
Intervallo di 52 settimane | 4,22 - 11,25 |
Volume | |
Media Volume | 519.295 |
Capitalizzazione | 2,005B |
Beta (5 anni mensile) | N/D |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -1,07 |
Prossima data utili | 08 nov 2022 |
Rendimento e dividendo (forward) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 7,92 |
SCOTTSDALE, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference, which will be hosted in San Francisco, CA. Details of the presentation are as follows:Presenters: Ken Burdick, Chairman and CEO, and Danish Qureshi, President and COODate: Tuesday, January 10, 2023 Time: 7:30 a.m. (Pacifi
SCOTTSDALE, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference, which will be hosted in San Francisco, CA. Details of the presentation are as follows:Presenters: Ken Burdick, Chairman and CEO, and Danish Qureshi, President and COODate: Tuesday, January 10, 2023 Time: 7:30 a.m. (Pacifi
SCOTTSDALE, Ariz., Nov. 08, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the quarter ended September 30, 2022. (All results compared to prior-year comparative period, unless otherwise noted) Q3 2022 Highlights and FY 2022 Outlook Revenue of $217.6 million increased $43.8 million or 25% compared to revenue of $173.8 millionTotal clinicians of 5,431 up 24%, a net i